Immune-based pharmacodynamic markers—such as rises in IFN-γ, dendritic-cell activation, CD8+ T-cell recruitment, or induction of PD-L1—provide additional evidence that the OV is converting the CRC microenvironment toward an immune-active state [132]. This evidence concerns the gene CD8A and colorectal carcinoma.